- $13.83bn
- $12.90bn
- $1.95bn
- 82
- 18
- 88
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,743 | 3,340 | 8,147 | 1,958 | 1,945 |
Cost of Revenue | |||||
Gross Profit | 1,311 | 1,583 | 2,161 | 1,600 | 1,524 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,990 | 3,380 | 8,492 | 2,051 | 2,214 |
Operating Profit | -247 | -39.9 | -345 | -93 | -269 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -310 | -170 | -527 | -85 | -154 |
Provision for Income Taxes | |||||
Net Income After Taxes | -305 | -162 | -528 | -88 | -158 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -305 | -162 | -528 | -101 | -158 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -305 | -162 | -528 | -101 | -158 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.48 | -0.505 | -0.794 | -0.275 | -0.615 |